Product catalog antigen listed by alphabetic starting with B
| Items 401 to 500 of 563 total | 6 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00066037-Q01-25 | BOLL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000680-Q01-10 | Bombesin Receptor Subtype 3 (BRS3) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000680-Q01-25 | Bombesin Receptor Subtype 3 (BRS3) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA213 | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Human | Purified | >98% | E. coli | 10 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA213X | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Human | Purified | >98% | E. coli | 50 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| BMP135-R-10 | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Purified | - | 10 µg / --- | |||||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP135-R-50 | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Human | Purified | - | 50 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP145-R-10 | Bone Morphogenetic Protein 14 (BMP14) antigen | ||||||
| Human | Purified | - | 10 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP145-R-50 | Bone Morphogenetic Protein 14 (BMP14) antigen | ||||||
| Human | Purified | - | 50 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| DA3502 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| DA3502X | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | E. coli | 25 µg / US$ 515 | |||
| Acris Antibodies GmbH | |||||||
| PA212 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >98% | E. coli | 2 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA212X | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >98% | E. coli | 10 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| BMP25-R | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | CHO cells | 10 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP25-R-10 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | - | 10 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| PR15013-10 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >90% | CHO cells | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15014-10 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15013CF-10 | Bone Morphogenetic Protein 2 (BMP2) (Carrier Free) antigen | ||||||
| Human | Purified | >95% | CHO cells | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15014CF-10 | Bone Morphogenetic Protein 2 (BMP2) (Carrier-Free) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| BMP35-R | Bone Morphogenetic Protein 3 (BMP3) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP3B36-R | Bone Morphogenetic Protein 3b (BMP3b) antigen | ||||||
| Human | Purified | >95% | E. coli | 5 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| AR01018PU-N | Bone Morphogenetic Protein 4 (BMP4) antigen | ||||||
| Human | Purified | >97% | HeLa-229 cells | 5 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| AR01018PU-S | Bone Morphogenetic Protein 4 (BMP4) antigen | ||||||
| Human | Purified | >97% | HeLa-229 cells | 1 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PR15015-10 | Bone Morphogenetic Protein 4 (BMP4) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15015CF-10 | Bone Morphogenetic Protein 4 (BMP4) (Carrier-Free) antigen | ||||||
| Human | Purified | >95% | NSO cells | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PA1006 | Bone Morphogenetic Protein 7 (BMP7) antigen | ||||||
| Human | Purified | >98% | CHO cells | 2 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA1006X | Bone Morphogenetic Protein 7 (BMP7) antigen | ||||||
| Human | Purified | >98% | CHO cells | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| BMP75-R | Bone Morphogenetic Protein 7 (BMP7) antigen | ||||||
| Human | Purified | >95% | CHO cells | 10 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| DA3521 | Bone Morphogenetic Protein Receptor 1A (BMPR1A ) antigen | ||||||
| Human | Purified | >90% | Insect cells | 0.1 mg / US$ 455 | |||
| Acris Antibodies GmbH | |||||||
| AR00019SU-N | Borrelia burgdorferi (afzelii) (PKo) antigen | ||||||
| Lysate | Cell culture | 1 mg / --- | |||||
| Acris Antibodies GmbH | |||||||
| AR00020PU-N | Borrelia burgdorferi (Lyme) Osp-C 23 kDa antigen | ||||||
| Purified | E. coli | 0.1 mg / --- | |||||
| Acris Antibodies GmbH | |||||||
| BA1111 | Borrelia burgdorferi (Osp A) antigen | ||||||
| Borrelia burgdorferi | Purified | >95% | recombinant | 0.1 mg / --- | |||
| Acris Antibodies GmbH | |||||||
| AR00021SU-N | Borrelia garinii antigen | ||||||
| Lysate | Cell culture | 1 mg / --- | |||||
| Acris Antibodies GmbH | |||||||
| H00000670-Q01-10 | BPHL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000670-Q01-25 | BPHL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010380-Q01-10 | BPNT1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010380-Q01-25 | BPNT1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000624-Q01-10 | Bradykinin B2 Receptor / BDKRB2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000624-Q01-25 | Bradykinin B2 Receptor / BDKRB2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000673-Q01-10 | BRAF antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000673-Q01-25 | BRAF antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010409-P01-10 | Brain Acid Soluble Protein 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010409-P01-25 | Brain Acid Soluble Protein 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1008 | Brain Natriuretic Peptide (BNP) antigen | ||||||
| Human | Purified | >95% | E. coli | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1008X | Brain Natriuretic Peptide (BNP) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1008XC | Brain Natriuretic Peptide (BNP) antigen | ||||||
| Human | Purified | >95% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| 8GNPB5 | Brain Natriuretic Peptide (NT-proBNP) (glycosylated) antigen | ||||||
| Human | Purified | >95 % | 0.05 mg / --- | ||||
| HyTest Ltd. | |||||||
| H00004879-P01-10 | Brain Natriuretic Peptide (proBNP) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004879-P01-25 | Brain Natriuretic Peptide (proBNP) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 8PRO8 | Brain Natriuretic Peptide (proBNP) (aa1-108) antigen | ||||||
| Human | Purified | >95% | E. coli | 0.1 mg / --- | |||
| HyTest Ltd. | |||||||
| 8GOB2 | Brain Natriuretic Peptide (proBNP) (glycosylated) antigen | ||||||
| Human | Purified | >95 % | 0.05 mg / --- | ||||
| HyTest Ltd. | |||||||
| 8NT1 | Brain Natriuretic Peptide (proBNP) (NT, aa1-76) antigen | ||||||
| Human | Purified | >98% | E. coli | 0.1 mg / --- | |||
| HyTest Ltd. | |||||||
| PA271 | BRAK antigen | ||||||
| Human | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA271X | BRAK antigen | ||||||
| Human | >98% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00000672-Q01-10 | BRCA1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000672-Q01-25 | BRCA1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PR26000-2 | BRCA1 antigen | ||||||
| Human | Purified | >95% | Insect cells | 2 µg / --- | |||
| Neuromics Antibodies | |||||||
| H00008314-Q01-10 | BRCA1-Associated Protein 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008314-Q01-25 | BRCA1-Associated Protein 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000580-Q01-10 | BRCA1-Associated RING Domain Protein 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000580-Q01-25 | BRCA1-Associated RING Domain Protein 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00414899-Q01-10 | BRCC2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00414899-Q01-25 | BRCC2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006046-Q01-10 | BRD2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006046-Q01-25 | BRD2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008019-Q01-10 | BRD3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008019-Q01-25 | BRD3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029117-P01-10 | BRD7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029117-P01-25 | BRD7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010902-Q01-10 | BRD8 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010902-Q01-25 | BRD8 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026228-Q01-10 | BRDG1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026228-Q01-25 | BRDG1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008537-Q01-10 | Breast Carcinoma-amplified Sequence 1 (BCAS1) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008537-Q01-25 | Breast Carcinoma-amplified Sequence 1 (BCAS1) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010286-P01-10 | Breast Carcinoma-amplified Sequence 2 (BCAS2) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010286-P01-25 | Breast Carcinoma-amplified Sequence 2 (BCAS2) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010286-Q01-10 | Breast Carcinoma-amplified Sequence 2 (BCAS2) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010286-Q01-25 | Breast Carcinoma-amplified Sequence 2 (BCAS2) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22346F | Breast Carcinoma-amplified Sequence 2 (BCAS2) antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22346F-50 | Breast Carcinoma-amplified Sequence 2 (BCAS2) antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00063827-Q01-10 | Brevican Core Protein antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00063827-Q01-25 | Brevican Core Protein antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00025855-P01-10 | BRMS1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00025855-P01-25 | BRMS1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009031-Q01-10 | Bromodomain adjacent to zinc finger domain protein 1B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009031-Q01-25 | Bromodomain adjacent to zinc finger domain protein 1B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007862-Q01-10 | BRPF1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007862-Q01-25 | BRPF1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023397-Q01-10 | BRRN1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023397-Q01-25 | BRRN1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084446-Q01-10 | BRSK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084446-Q01-25 | BRSK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026580-Q01-10 | BSCL2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026580-Q01-25 | BSCL2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026580-Q02-10 | BSCL2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026580-Q02-25 | BSCL2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000683-P01-10 | BST1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000683-P01-25 | BST1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009044-Q01-10 | BTAF1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009044-Q01-25 | BTAF1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 401 to 500 of 563 total | 6 Page(s): |


